Annals of Surgical Oncology, Vol 4, Issue 7 586-590, Copyright © 1997 by Society of Surgical Oncology

ARTICLES

Prospective cohort study of neoadjuvant treatment in conservative surgery of soft tissue sarcomas

W. J. Temple, C. L. Temple, K. Arthur, N. S. Schachar, A. H. Paterson and T. S. Crabtree
Department of Surgical Oncology, University of Calgary, Alberta, Canada.

BACKGROUND: 1994 marked a decade since the inception of a prospective population-based study on the value of neoadjuvant approach for soft tissue sarcomas of head, neck, and limbs at the Tom Baker Cancer Centre, Calgary, Alberta. To date, 42 patients have been followed for a minimum of 5 years or until death. METHODS: Each patient received a protocol of 60 mg to 90 mg of Adriamycin infused intra-arterially or intravenously over 3 days into a vessel feeding the involved area, 30 Gy of radiotherapy given over 10 days, and complete resection of the sarcoma 4 to 6 weeks later. The lower dose was used empirically for smaller limbs (e.g., arm). RESULTS: Two of the 42 patients were immediate failures of protocol, with one requiring amputation and one requiring later reexcision. In the 38 appendicular lesions, the ultimate limb salvage rate was 97.5%. All tumors were associated with a high risk of local recurrence with 15 being previous local failures. The rest were deep and grade 2 or 3 lesions. Serious local complications were seen in one patient (2.5%) who had wound necrosis requiring reoperation. Minor wound complications were seen in five patients (12.5%) (one wound infection, one resolved edema, three long-term drainage). There was one local recurrence; thus 5-year local control was 97%. No patient had long-term morbidity related to the treatment. No effect on systemic control was suggested. CONCLUSION: Our report demonstrates that this combined modality approach provides superior local control of soft tissue sarcomas with low postoperative morbidity.

This article has been cited by other articles:

				M. A. F. Hegazy, S. Z. Kotb, H. Sakr, E. El Dosoky, T. Amer, R. A. F. Hegazi, and O. Farouk Preoperative Isolated Limb Infusion of Doxorubicin and External Irradiation for Limb-Threatening Soft Tissue Sarcomas Ann. Surg. Oncol., February 1, 2007; 14(2): 568 - 576. [Abstract] [Full Text] [PDF]

				L. A. Mack, P. J. Crowe, J. L. Yang, N. S. Schachar, D. G. Morris, E. C. Kurien, C. L. F. Temple, R. L. Lindsay, E. Magi, W. G. DeHaas, et al. Preoperative Chemoradiotherapy (Modified Eilber Protocol) Provides Maximum Local Control and Minimal Morbidity in Patients With Soft Tissue Sarcoma Ann. Surg. Oncol., August 1, 2005; 12(8): 646 - 653. [Abstract] [Full Text] [PDF]

				E. M. Noorda, B. C. Vrouenraets, O. E. Nieweg, F. van Coevorden, and B. B.R. Kroon Isolated Limb Perfusion: What Is the Evidence for Its Use? Ann. Surg. Oncol., September 1, 2004; 11(9): 837 - 845. [Abstract] [Full Text] [PDF]

				P. W.T. Pisters, S. R. Patel, V. G. Prieto, P. F. Thall, V. O. Lewis, B. W. Feig, K. K. Hunt, A. W. Yasko, P. P. Lin, M. G. Jacobson, et al. Phase I Trial of Preoperative Doxorubicin-Based Concurrent Chemoradiation and Surgical Resection for Localized Extremity and Body Wall Soft Tissue Sarcomas J. Clin. Oncol., August 15, 2004; 22(16): 3375 - 3380. [Abstract] [Full Text] [PDF]

				J. N. Cormier and R. E. Pollock Soft Tissue Sarcomas CA Cancer J Clin, March 1, 2004; 54(2): 94 - 109. [Abstract] [Full Text] [PDF]

				P. W. T. Pisters, M. T. Ballo, and S. R. Patel Preoperative Chemoradiation Treatment Strategies for Localized Sarcoma Ann. Surg. Oncol., July 1, 2002; 9(6): 535 - 542. [Abstract] [Full Text] [PDF]